USD 1.39 billion
Global Microbiome Sequencing Services Market Size, Share, Growth Analysis, By Type(Amplicon, whole-genome), By Application(Autoimmune disorder, cancer), By Technology(Sequencing by synthesis, sequencing by ligation) - Industry Forecast 2024-2031
Report ID:
SQMIG35J2091 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
90 |
Figures:
76
Global Microbiome Sequencing Services Market Insights
Global Microbiome Sequencing Services Market size was valued at USD 1.39 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 3.48 billion by 2031, growing at a CAGR of 10.7% in the forecast period (2024-2031).
The global market for microbiome sequencing services is poised for significant growth in the foreseeable future. The growth of the market is driven by two main factors: the increasing research on genomics-based gut studies and the rising demand for Next-generation Sequencing (NGS). The term "microbiome" refers to the collective presence of bacteria, fungi, viruses, and protists in and on the human body and the surrounding environment. To identify the microorganisms in a specific microbiome, researchers are utilizing metagenomics sequencing, a process that involves continuously sequencing genetic information from various organisms. Microbiome sequencing has gained significant attention in the scientific community due to its potential to offer advanced techniques for disease diagnosis, treatment, and prognosis. The introduction of new methodologies such as NGS and bioinformatics algorithms has led to a significant shift in clinical microbiology and infectious disease research, primarily due to the complex interactions within the microbiome. Various research institutes are developing advanced tools to enhance microbiome sequencing analysis, which will contribute to market growth in the coming years. For example, in May 2022, the Texas Biomedical Research Institute collaborated with Tulane University researchers to develop a software tool called a meta-transcriptome detector (MTD). This tool simplifies and accelerates the evaluation of genetic data related to a host and its microbiome simultaneously. It is useful for drug developers and microbiologists studying various human medical conditions such as cancer, HIV/AIDS, and malaria. Similarly, in January 2022, the Chinese Academy of Sciences supported a research team from the Qingdao Institute of Bioenergy and Bioprocess Technology (QIBEBT) in creating a low-cost metagenome sequencing technology. This technology allows for high-resolution analysis of the entire range of species in a microbiome, even in samples with low biomass, damage, or contamination. The development of cost-effective solutions and the decreasing testing costs are expected to increase the adoption of microbiome sequencing services in low-income and emerging countries, thereby supporting market growth in these regions.
US Microbiome Sequencing Services Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Whole-genome
Fastest Growth
Amplicon
Growth Rate
10.7% CAGR
Global Microbiome Sequencing Services Market ($ Bn)
Country Share for North America Region (%)
Global Microbiome Sequencing Services Market By Type ($ Bn)
Global Microbiome Sequencing Services Market By Type (%)
To get more reports on the above market click here to Buy The Report
Global Microbiome Sequencing Services Market Segmental Analysis
The Global Microbiome Sequencing Services Market is segmented by type, application, technology and region. Based on type, the market can be segmented into amplicon, whole-genome, shotgun sequencing and others. Based on application, the market is segmented into autoimmune disorder, cancer, gastrointestinal disorders and others. Based on technology, the market can be segmented into sequencing by synthesis, sequencing by ligation, sanger sequencing and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis by Type
Whole-genome sequencing is currently the dominant segment in the market. Whole-genome sequencing involves the sequencing of an organism's complete DNA, providing a comprehensive view of its genetic makeup. This approach allows for a thorough analysis of the entire genome, enabling researchers to identify variations, mutations, and potential disease-causing genes. The dominance of whole-genome sequencing can be attributed to its extensive applicability in various fields, including clinical diagnostics, personalized medicine, and genetic research. Its ability to provide a comprehensive understanding of an organism's genome makes it a valuable tool for advancing scientific knowledge and improving healthcare outcomes.
The fastest-growing segment in the market is amplicon sequencing. Amplicon sequencing focuses on specific regions of the genome by amplifying and sequencing targeted DNA regions of interest. This method offers several advantages, such as cost-effectiveness, faster turnaround time, and high sensitivity. Amplicon sequencing is widely used in microbiome research, where it allows for the targeted analysis of specific microbial communities or functional genes within a microbiome sample. The increasing interest in studying the microbiome and its impact on human health has driven the rapid growth of amplicon sequencing. Researchers are utilizing this method to gain insights into the composition and functionality of microbial communities, leading to advancements in fields like gut health, infectious diseases, and environmental microbiology. The convenience and efficiency of amplicon sequencing make it a preferred choice for many researchers, contributing to its status as the fastest-growing segment in the market.
Analysis by Application
The market is currently dominated by the gastrointestinal disorders segment. Extensive research on the microbiome has provided valuable insights into various gut-related diseases, including Crohn's disease, diabetes, ulcerative colitis, and gastrointestinal cancers. The increasing prevalence of gut-related diseases worldwide has significantly contributed to the revenue generated by this segment. Moreover, the continuous advancements in sequencing technologies for studying gut microbiota have spurred research and development activities, further driving the growth of this segment.
On the other hand, the autoimmune disorder segment is experiencing rapid growth and is expected to continue expanding in the foreseeable future. The human microbiome is believed to play a significant role in autoimmunity as alterations in microbial composition can lead to the loss of immune tolerance. With an estimated 3-5% of the global population affected by autoimmune diseases, which occur when the immune system attacks the body's own tissues, there is a growing demand for advanced microbiome sequencing services. Additionally, healthcare professionals are becoming increasingly aware of the availability and benefits of these services for early detection and management of autoimmune diseases. These factors are anticipated to drive significant growth in the autoimmune disorder segment during the forecast period.
Global Microbiome Sequencing Services Market By Type, 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Microbiome Sequencing Services Market Regional Insights
North America is currently the dominant region in the microbiome sequencing market. The region has a well-established healthcare infrastructure, a strong presence of key market players, and a high level of research and development activities in the field of genomics and microbiology. Additionally, North America has witnessed significant government support and funding for microbiome research, contributing to the market's growth. The presence of advanced sequencing technologies, a large patient pool for clinical trials, and collaborations between research institutions and pharmaceutical companies further strengthen North America's dominance in the microbiome sequencing market.
The Asia Pacific region is expected to be the fastest-growing segment in the microbiome sequencing market. The region is experiencing rapid advancements in healthcare infrastructure, increased focus on precision medicine, and a growing awareness of the importance of microbiome research. Factors such as a large population base, rising disposable income, and increasing healthcare expenditure are driving the demand for advanced sequencing technologies and microbiome research in the region. Additionally, the presence of emerging economies such as China and India, with their focus on research and development, is propelling the growth of the microbiome sequencing market in the Asia Pacific region. The increasing collaborations between regional and international research institutions and the adoption of next-generation sequencing technologies are expected to further fuel the growth of this segment in the coming years.
Global Microbiome Sequencing Services Market By Region, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Microbiome Sequencing Services Market Dynamics
Drivers
Increasing recognition of the microbiome's impact on human health and disease
- One key driver of the microbiome sequencing market is the growing recognition of the microbiome's impact on human health and disease. The microbiome has been linked to various health conditions, including gastrointestinal disorders, autoimmune diseases, and cancer. As researchers and healthcare professionals gain a better understanding of the microbiome's role in disease development, there is a rising demand for microbiome sequencing services to explore its potential applications in diagnosis, treatment, and personalized medicine. This growing recognition and awareness of the microbiome's significance are driving the market forward.
Restraints
Complexity and variability of the microbiome
- One key restraint of the microbiome sequencing market is the complexity and variability of the microbiome itself. The microbiome is highly diverse, with individual variations and dynamic changes influenced by various factors such as diet, lifestyle, and environmental factors. This complexity poses challenges in standardizing and interpreting microbiome sequencing data. The lack of standardized protocols and reference databases for microbiome analysis can lead to inconsistencies and discrepancies in results, affecting the reliability and reproducibility of findings. Moreover, the interpretation and understanding of the functional implications of microbiome data are still evolving, which may hinder the widespread adoption and utilization of microbiome sequencing in clinical settings. Overcoming these challenges and establishing robust methodologies and standards will be crucial for the continued growth and acceptance of microbiome sequencing.
Request Free Customization of this report to help us to meet your business objectives.
Global Microbiome Sequencing Services Market Competitive Landscape
The competitive landscape of the microbiome sequencing market is characterized by intense competition and a presence of various stakeholders, including research institutions, biotechnology firms, sequencing service providers, and academic organizations. These players are actively involved in research and development activities to enhance sequencing technologies, develop innovative analysis tools, and expand their service offerings. Partnerships, collaborations, and strategic alliances are common strategies employed by market players to strengthen their market position and gain a competitive edge. The market is dynamic, with continuous advancements in sequencing technologies and bioinformatics tools, which drive the competitive environment and foster innovation within the microbiome sequencing market.
Top Player’s Company Profiles
- Clinical-Microbiomics A/S (Denmark)
- Mérieux NutriSciences Corporation (US)
- Metabiomics Corp. (US)
- Rancho BioSciences (US)
- Second Genome (US)
- Zymo Research Corporation (US)
- uBiome, Inc. (US)
- Illumina, Inc. (US)
- Thermo Fisher Scientific Inc. (US)
- QIAGEN N.V. (Netherlands)
- Oxford Nanopore Technologies Ltd. (UK)
- BGI Genomics Co., Ltd. (China)
- CosmosID Inc. (US)
- Diversigen Inc. (US)
- Molecular Research LP (US)
- Microbiome Therapeutics, LLC (US)
- Bio-Rad Laboratories, Inc. (US)
Recent Developments
-
In March 2024, Carbiotix announced the Company’s first ever animal-related LinkGut service order from a leading company developing microbiome intervention solutions for different human and animal applications.
-
In November 2023, QIAGEN N.V. QGEN announced the launch of the Microbiome WGS (whole-genome sequencing) SeqSets — a comprehensive Sample to Insight workflow designed to provide an easy-to-use solution that maximizes efficiency and reproducibility in microbiome research.
-
In October 2023, PacBio, a leading developer of high-quality, highly accurate sequencing solutions, announced that it has begun taking orders for its groundbreaking Kinnex RNA kits, which increase throughput for full-length RNA, single-cell RNA, and 16S rRNA sequencing on PacBio's long-read sequencing systems to enable large-scale studies at a resolution difficult to attain with short-read RNA sequencing.
Global Microbiome Sequencing Services Key Market Trends
- One key market trend in the microbiome sequencing market is the increasing focus on personalized medicine and precision therapeutics. As researchers and healthcare professionals delve deeper into understanding the role of the microbiome in human health and disease, there is a growing emphasis on tailoring treatments and interventions based on an individual's unique microbiome composition. This trend is driving the development of advanced sequencing technologies, bioinformatics tools, and data analytics platforms to enable accurate profiling and analysis of the microbiome. The integration of microbiome data with other clinical and genetic information is paving the way for personalized medicine approaches that consider an individual's microbiome profile for more targeted and effective therapeutic interventions.
Global Microbiome Sequencing Services Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, the global microbiome sequencing market is experiencing significant growth and advancements in understanding the complex microbial communities that exist in and on the human body. The market is driven by factors such as the surge in genomics-based gut research, the growing demand for Next-generation Sequencing (NGS), and the potential of microbiome sequencing in disease diagnosis, treatment, and prognosis. The dominant segments in the market include Gastrointestinal disorders in terms of application and North America in terms of region. Autoimmune disorders are identified as the fastest-growing segments. The market is characterized by intense competition among various stakeholders, including research institutions, biotechnology firms, and sequencing service providers. Key drivers include the recognition of the microbiome's impact on human health, while key restraints include the complexity and variability of the microbiome itself. The market is also witnessing trends towards personalized medicine and precision therapeutics, leveraging the unique characteristics of individuals' microbiomes for targeted interventions. Overall, the microbiome sequencing market holds significant potential for further advancements in healthcare and personalized treatment approaches.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.39 billion |
| Market size value in 2031 | USD 3.48 billion |
| Growth Rate | 10.7% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Microbiome Sequencing Services Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Microbiome Sequencing Services Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Microbiome Sequencing Services Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Microbiome Sequencing Services Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Microbiome Sequencing Services Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Microbiome Sequencing Services Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Microbiome Sequencing Services Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
